1. FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX‐bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study. Issue 11 (14th July 2022) Authors: Torregrosa, Cécile; Pernot, Simon; Vaflard, Pauline; Perret, Audrey; Tournigand, Christophe; Randrian, Violaine; Doat, Solene; Neuzillet, Cindy; Moulin, Valérie; Stouvenot, Morgane; Roth, Gael; Darbas, Tiffany; Auberger, Benjamin; Godet, Tiphaine; Jaffrelot, Marion; Lambert, Aurélien; Dubreuil, O... Journal: International journal of cancer Issue: Volume 151:Issue 11(2022) Page Start: 1978 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Withholding the Introduction of Anti‐Epidermal Growth Factor Receptor: Impact on Outcomes in RAS Wild‐Type Metastatic Colorectal Tumors: A Multicenter AGEO Study (the WAIT or ACT Study). (2nd October 2019) Authors: Palmieri, Lola‐Jade; Mineur, Laurent; Tougeron, David; Rousseau, Benoît; Granger, Victoire; Gornet, Jean‐Marc; Smith, Denis; Lievre, Astrid; Galais, Marie‐Pierre; Doat, Solene; Pernot, Simon; Bignon‐Bretagne, Anne‐Laure; Metges, Jean‐Philippe; Baba‐Hamed, Nabil; Michel, Pierre; Obled, Stéphane; V... Journal: Oncologist Issue: Volume 25:Number 2(2020) Page Start: e266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗